new oral glp 1 agonist Not an April fool's prank! The small molecule GLP-1 receptor agonist, orforglipron, has been approved by the FDA under the trade name, "Foundayo." We discussed the data in a fall 2025 episode Orforglipron, an Oral Small-Molecule GLP-1

This ingredient is available in the form of creams and lotions

Renal complications Diabetic kidney disease is a complication of diabetes that leads to increased mortality (40)

Alzheimers Res Ther 13(1):114 Kiss E et al (2022) Artemisinin-treatment in pre-symptomatic APP-PS1 mice increases gephyrin phosphorylation at Ser270: a modification regulating postsynaptic GABA(A)R density

and has participated on the Data and Safety Monitoring Board or Advisory Board for Medtronic and Novo Nordisk

In people with ASD, mutations or polymorphisms in the Reelin gene (RELN), such as at the rs736707 locus, can lead to reduced Reelin expression